4//SEC Filing
Hui Liu 4
Accession 0001493152-20-022913
CIK 0001582554other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:08 PM ET
Size
5.6 KB
Accession
0001493152-20-022913
Insider Transaction Report
Form 4
Hui Liu
Chief Technology Officer
Transactions
- Award
Stock option (right to buy)
2020-12-01+350,000→ 350,000 totalExercise: $1.07Exp: 2030-12-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests as to 25% on December 1, 2021, thereafter the remaining options vest in equal monthly installments over a period of 36 months commencing on January 1, 2022.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001834660
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 4:08 PM ET
- Size
- 5.6 KB